Serum Proteins Enhance Dispersion Stability and Influence the Cytotoxicity and Dosimetry of ZnO Nanoparticles in Suspension and Adherent Cancer Cell Models by Anders, Catherine B. et al.
Boise State University
ScholarWorks
Biomolecular Research Center Publications and
Presentations Biomolecular Research Center
11-1-2015
Serum Proteins Enhance Dispersion Stability and
Influence the Cytotoxicity and Dosimetry of ZnO
Nanoparticles in Suspension and Adherent Cancer
Cell Models
Catherine B. Anders
Boise State University
Jordan J. Chess
Boise State University
Denise G. Wingett
Boise State University
Alex Punnoose
Boise State University
This document was originally published in Nanoscale Research Letters by Springer. This work is provided under a Creative Commons Attribution 4.0
International license. Details regarding the use of this work can be found at: http://creativecommons.org/licenses/by/4.0/. The final publication is
available at doi: http://dx.doi.org/10.1186/s11671-015-1158-y
Publication Information
Anders, Catherine B.; Chess, Jordan J.; Wingett, Denise G.; and Punnoose, Alex. (2015). "Serum Proteins Enhance Dispersion
Stability and Influence the Cytotoxicity and Dosimetry of ZnO Nanoparticles in Suspension and Adherent Cancer Cell Models".
Nanoscale Research Letters, 10, 448. http://dx.doi.org/10.1186/s11671-015-1158-y
NANO EXPRESS Open Access
Serum Proteins Enhance Dispersion
Stability and Influence the Cytotoxicity and
Dosimetry of ZnO Nanoparticles in
Suspension and Adherent Cancer Cell
Models
Catherine B. Anders1,2, Jordan J. Chess1,4, Denise G. Wingett2,3 and Alex Punnoose1,2*
Abstract
Agglomeration and sedimentation of nanoparticles (NPs) within biological solutions is a major limitation in their use
in many downstream applications. It has been proposed that serum proteins associate with the NP surface to form
a protein corona that limits agglomeration and sedimentation. Here, we investigate the effect of fetal bovine serum
(FBS) proteins on the dispersion stability, dosimetry, and NP-induced cytotoxicity of cationic zinc oxide nanoparticles
(nZnO) synthesized via forced hydrolysis with a core size of 10 nm. Two different in vitro cell culture models,
suspension and adherent, were evaluated by comparing a phosphate buffered saline (PBS) nZnO dispersion
(nZnO/PBS) and an FBS-stabilized PBS nZnO dispersion (nZnO – FBS/PBS). Surface interactions of FBS on nZnO
were analyzed via spectroscopic and optical techniques. Fourier transformed infrared spectroscopy (FTIR)
confirmed the adsorption of negatively charged protein components on the cationic nZnO surface through the
disappearance of surfaced-adsorbed carboxyl functional groups and the subsequent detection of vibrational modes
associated with the protein backbone of FBS-associated proteins. Further confirmation of these interactions was noted
in the isoelectric point shift of the nZnO from the characteristic pH of 9.5 to a pH of 6.1. In nZnO – FBS/PBS dispersions,
the FBS reduced agglomeration and sedimentation behaviors to impart long-term improvements (>24 h) to the nZnO
dispersion stability. Furthermore, mathematical dosimetry models indicate that nZnO – FBS/PBS dispersions had
consistent NP deposition patterns over time unlike unstable nZnO/PBS dispersions. In suspension cell models, the
stable nZnO – FBS/PBS dispersion resulted in a ~33 % increase in the NP-induced cytotoxicity for both Jurkat
leukemic and Hut-78 lymphoma cancer cells. In contrast, the nZnO – FBS/PBS dispersion resulted in 49 and 71 %
reductions in the cytotoxicity observed towards the adherent breast (T-47D) and prostate (LNCaP) cancer cell
lines, respectively. Presence of FBS in the NP dispersions also increased the reactive oxygen species generation.
These observations indicate that the improved dispersion stability leads to increased NP bioavailability for
suspension cell models and reduced NP sedimentation onto adherent cell layers resulting in more accurate in
vitro toxicity assessments.
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Background
When prepared in nanostructured form, many materials
develop novel and unique physicochemical properties
leading to their use in nanotechnology applications such
as quantum dots and MRI contrast agents for imaging
[1], biosensors that use surface plasmon resonance [2],
and nanomedicinal approaches that employ hyperther-
mia and photothermal therapy [3]. Efficient use of NPs
and nanocarriers in biomedical applications, such as
delivery of therapeutic and imaging agents into tumor
sites and genetic materials into cells, has been success-
fully demonstrated in recent years [4–6]. Interestingly,
cytotoxicity is a property that is inherent in many of
these commonly used materials when they are synthe-
sized with their crystallite size in the nanoscale range
[7–9]. This has raised significant scientific and public
concerns on the environmental and health effects of
every nanomaterial before employing them in nanotech-
nology applications. It is therefore necessary to evaluate
the cytotoxic response of nanomaterials and the under-
lying mechanisms of nanomaterial toxicity to accurately
address the growing concerns about the impact of the
unwanted cytotoxicity of nanomaterials.
Numerous studies reported in the literature have shown
that NP-induced toxicity depends on the nanomaterial
properties such as crystallite size [10, 11], shape [12],
charge [13], and chemical phase [14]. Some studies have
also shown that the toxic response of a given nanomaterial
might vary with the specific cell/organism type such as
prokaryotes versus eukaryotes [15], gram-positive bacteria
versus gram-negative bacteria, and normal cells versus
cancerous cells [16]. These observations suggest that the
role of organism-specific factors such as surface structure
of cells [17, 18] and the proliferation status [10, 16] also
influence the toxic response. Although the cytotoxicity of
nanomaterials is an unfavorable feature for many applica-
tions, it could become very useful for certain therapeutic
applications, if the toxicity is cell- or organism-specific.
The cytotoxicity reported for most nanomaterials does
not display a cell-specific or organism-specific behavior.
However, many groups [16, 19, 20], including the authors,
have demonstrated that certain ZnO NP formulations
show a strong preferential cytotoxicity to cancer cells of
identical lineage. For example, while resting primary
human immune cells (T lymphocytes) showed no appre-
ciable effect when treated with ≤5 mM concentrations of
ZnO NPs, cancer cells of the same lineage showed signifi-
cantly increased NP-induced toxicity resulting in approxi-
mately 28–35-fold increases in NP sensitivity [10, 16].
Thus, toxicity studies are extremely important both to as-
sess the environmental and health impacts of NPs and to
modify the nanomaterial design to make them safer, as
well as to develop novel nanomedicinal approaches utiliz-
ing cell-specific cytotoxicity.
Considering the large number and types of new nano-
materials being developed and coming to the market, in
vitro studies are essential in assessing the toxicity in high-
throughput systems as they provide rapid and cost-
effective screening. In most in vitro cytotoxicity experi-
ments, cells are cultured in a culture medium to which a
prepared dispersion of the NPs in a suitable solution is
introduced. In contrast, in vivo toxicology studies fre-
quently employ NPs dispersed in a suitable medium that
are subsequently injected into the blood vessels or tissues
of the animal model. If successful, the dispersed NPs will
reach tumor sites and achieve deep penetration and
entrapment in the cancerous tissue by means of the
enhanced permeability and retention (EPR) effect, charac-
terized by increased vascular permeability and compressed
lymphatic networks in solid tumors [21]. However, mak-
ing highly stable and efficient dispersions of nanoparticles
to achieve efficient nanoparticle delivery for both in vitro
and in vivo applications has been a challenging task. A
major difference that NPs possess compared to the well-
studied conventional toxic chemicals (which are well sol-
uble molecules and ions) is the difficulty in dispersing
them in suitable solutions and culture media and to main-
tain them as stable dispersions for sufficient durations
[22]. For most in vitro studies, NP suspensions should
remain stable at least for 24 h while in vivo studies require
stability for much longer durations [23]. Formation of
large agglomerates and their sedimentation over longer
periods often prevents a significant fraction of the NPs
from participating in efficient interactions with the test
cells and the resulting cytotoxic response.
Nanoparticle dispersion stability is a complex interplay
between the agglomerate size of NP complexes in dis-
persion (hydrodynamic size) and their sedimentation
behavior over time [24]. Factors that affect NP stability
include NP size [25, 26], surface structure [18, 27], cap-
ping agents [28], pH [29], ionic strength [29], organic
and protein components [26, 27, 30], and free ions in
the solution system [31]. Although it is now known that
the physicochemical properties of the nanomaterial, the
specific cell/organism type, and the membrane proper-
ties [10, 17, 18] of the test organism play a crucial role
in the resulting cytotoxic response, very few studies have
focused on the important role of NP dispersion charac-
teristics and dispersion stability and the effects of NP
agglomeration and sedimentation in the resulting tox-
icity [32, 33]. Furthermore, Cho et al. [34] have recently
shown that the cellular uptake of gold NP in breast can-
cer cells measured using conventional upright in vitro
cell culture configuration was significantly higher than
that obtained when an inverted setup was used, suggest-
ing the effect of NP sedimentation and diffusion in the
media play a significant role in the NP-cell interaction.
In addition, suspension stability has been shown to
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directly influence effective administered dose of NPs to
adherent cells grown in vitro [22, 32, 33].
When NPs are introduced to biological fluids such as
human plasma, a biomolecular corona consisting of pro-
teins and small molecules rapidly forms on the NP sur-
face [27, 35–37]. Since the blood circulatory system is
the most probable treatment administration option for
NPs into the human body, it is important to investigate
how adsorption of blood proteins on NPs will affect the
cellular response, and more importantly, the differential
cytotoxicity of ZnO NPs between cancerous and normal
cells. The effect of having serum in culture medium
and/or adsorption of the serum proteins on some NP
systems such as silica [38], carbon nanotubes [39], gra-
phene oxide [40], and ZnO [41, 42] has been studied
recently. In all these cases, the primary effects of serum
addition included improved dispersion stability and a
clear reduction of the NP-induced cytotoxicity. Interest-
ingly, the abovementioned studies were conducted using
adherent cell models; therefore, comprehensive studies are
needed to determine if similar responses are present for
suspension cell models as well. Hypothetically, increases
in the NP-induced toxicity in suspension cell models
would be observed as NP sedimentation decreases,
thereby improving the bioavailability of the NPs to the
cells.
In this study, we investigated the use of FBS as a ZnO
NP coating agent and the effects of this FBS coating the
surface structure of the uncoated NPs, the dispersive sta-
bility of the NPs in solution, and the effective dosimetry of
the NPs in cellular toxicity assays. Since NP dispersion
stability and dosimetry is highly dependent upon a balance
of NP diffusion and sedimentation velocities within a solu-
tion [32–34, 43, 44], the use of multiple suspension and
adherent cell models was necessary to fully characterize
any observations attributable to the addition of the FBS. A
complete NP characterization profile was employed to
fully interrogate NP surface changes as a result of the FBS
coating. In addition, we examined the agglomeration and
sedimentation behavior of the FBS-coated ZnO NPs
(nZnO – FBS) compared to uncoated ZnO NP (nZnO)
in biologically relevant solutions. Finally, we investi-
gated the effects that FBS coating would have on the
solubility of the nZnO, the NP-induced toxicity, and
nZnO-induced reactive oxygen species production. As a
whole, this work provides a comprehensive look at effects
of FBS as a dispersion stabilizing agent in nanotoxicology
studies.
Methods
Synthesis and Characterization of nZnO
The nZnO sample used in this study was produced using
the forced hydrolysis of Zn acetate dehydrate precursor
in diethylene glycol (DEG). The solution was held at
150 °C for 90 min. Nanopure water was added to the so-
lution at 80 °C to obtain the desired crystallite size. This
synthesis method allows for excellent control of the
crystallite size by carefully regulating the temperature
parameters and the hydrolysis ratio of the reaction
media [10]. Once cooled to room temperature, the
nZnO were separated from solution via centrifuging at
20,000 rpm and subsequent washings with ethanol. A
dried FBS-coated (nZnO – FBSdried) sample was pre-
pared by sonicating the nZnO with FBS for 10 min. The
resulting suspension was then centrifuged, and the
resulting pellet rinsed several times with nanopure water
to remove any unbound FBS. The pellet was dried over-
night at 60 °C to create a powdered nZnO – FBSdried
form for material characterization. Both NP samples
were thoroughly characterized and investigated in detail
using X-ray diffraction (XRD), transmission electron mi-
croscopy (TEM), zeta potential measurements, UV-vis
spectrophotometry, and Fourier transformed infrared
spectroscopy (FTIR). X-ray diffraction (XRD) spectra
were recorded at room temperature on a Philips X’Pert
X-ray diffractometer with a Cu Kα source (λ = 1.5418 Å)
in Bragg-Brentano geometry. The loose powder samples
were leveled in the sample holder to ensure a smooth
surface and mounted on a fixed horizontal sample plane.
Lattice parameters and crystal size were analyzed with
Rietveld refinement using Materials Analysis Using Dif-
fraction (MAUD) software, corrected for instrumental
broadening [45]. TEM and high-resolution TEM analysis
was carried out using an FEI Tecnai and FEI Titan,
respectively. The operating voltage of the Tecnai micro-
scope was 120 and 300 kV on the Titan. Image processing
was carried out using the Digital Micrograph software
from Gatan (Pleasant, CA, USA). Room-temperature
optical spectra in the ultraviolet and visible light wave-
length ranges were collected using a CARY 5000 spectro-
photometer. Zeta potentials of the powdered samples of
nZnO were measured in nanopure water as a function of
pH with a Malvern Zetasizer NanoZS. The temperature
was equilibrated to 25 °C, and the pH was varied in the 6
to 12 range using 1.0 N HCl and 1.0 N NaOH prior to col-
lecting the data. At least six data collections per run were
performed on three separate aliquots of the ZnO suspen-
sion for each sample. The Zetasizer unit was also used to
measure the hydrodynamic size of nZnO aggregates dis-
persed in selected media. Several solution systems were
used for NP stock preparation and analyzed during this
experiment.
NP Stock Preparation
To achieve the most stable dispersion for each solution,
the critical material-specific delivered sonication energy
(DSEcr) for the ZnO NPs was predetermined for the ca-
lorimetrically calibrated JSP Super-sonic bath sonication
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device employed for this study. A DSEcr of 181 J/ml was
established through established protocols outlined by Taur-
ozzi et al. (2011) [46] and employed in multiple dosimetry
studies [33, 47]. To achieve the needed DSEcr, ZnO NPs
were suspended at concentrations of 25 mM and sonicated
in the bath sonicator delivering a power of 1.05 W for a
total 30 min. Several biologically relevant solutions were
prepared per manufacturer’s instructions unless otherwise
defined. They include nanopure water, PBS, FBS, Roswell
Park Memorial Institute (RPMI) medium (RPMI 1640
buffered with sodium bicarbonate and Hepes, pH adjusted
to 7.3), RPMI-based cellular medium (RPMI 1640 medium
supplemented with 10 % FBS and 2 mM L-glutamine,
1.5 g/l sodium bicarbonate, 4.5 g/l glucose, 10 mM HEPES,
1.0 mM sodium pyruvate and penicillin-streptomycin), and
DMEM-based cellular medium.
In addition to single solution NP dispersions, several NP
stock dispersions were prepared with FBS. Based on most
of the reported protocols found in the literature and our
own preliminary data, 10 % FBS addition was found to
provide optimal results and was used to prepare these
stock dispersions. The stock dispersions involved first sus-
pending the desired quantity of NPs in a volume of FBS
equivalent to 10 % of the final solution volume and sonic-
ating at 1.05 W for 10 min. After sonication, the FBS sus-
pension was diluted to the calculated volume with the
desired medium (90 % of the total volume) and re-
sonicated at 1.05 W for an additional 20 min. These stock
dispersions are referred to as either nZnO – FBS/water or
nZnO – FBS/PBS for stocks prepared in nanopure water
or PBS, respectively. Additionally, two nZnO – FBS for-
mulations were created by removing the excess FBS prior
to re-suspension and sonication in the appropriate solu-
tion. One formulation involved centrifuging the nZnO/
FBS suspension after the initial sonication period followed
by several washes with nanopure water to remove any un-
bound FBS. The remaining pellet was then re-suspended
in the desired solution to the appropriate concentration to
create nZnO – FBSwashed/water or nZnO – FBSwashed/PBS
for nanopure water and PBS dispersions, respectively.
Finally, stock dispersions for the dried sample, described
in the previous section, are designated as nZnO –
FBSdried/water and nZnO – FBSdried/PBS for nanopure
and PBS dispersions, respectively.
Extracellular Dissolution
For extracellular dissolution experiments, nZnO stock
dispersions were prepared as previously described at
6 mM concentrations. To simulate cellular assay condi-
tions, an aliquot of each stock dispersion was added to
cellular media at a final nZnO concentration of 0.6 mM.
All dispersions were stirred continuously to prevent
nZnO sedimentation. At desired time points, an aliquot
of the sample was removed and centrifuged at 5000×g
for 20 min using an Amicon™ Ultra-4 Centrifugal Filter
Unit with a 3-kD molecular weight cutoff (0.1 nm pore
size) to remove any undissolved nZnO while allowing
free zinc ions to pass through. Quantitative analysis of
the dissolved Zn2+ ions was conducted on a Thermo X
Series 2 quadrupole inductively coupled plasma mass
spectrometer (ICP-MS) under normal operating condi-
tions (i.e., no CCT) with the Xt cone set. Instrument
performance was evaluated and optimized for each run.
The instrument was calibrated using multi-element cali-
bration standards containing Zn, Cr, Mn, Fe, Co, and Ni
in 2 % HNO3 at concentrations of approximately 1, 10,
100, and 1000 ppb. Instrument drift was monitored and
corrected using 20 ppb indium as an internal standard
introduced online.
Dosimetry Analysis and Empirical Deposition Fractions
Since NPs suspended in solution often form loosely
packed agglomerates consisting of NP clusters and
entrapped media, two empirical methods, the Harvard
Volume Centrifugation Method (VCM) [32, 33] and the
in vitro sedimentation, diffusion, and dosimetry (ISDD)
computational model [43], were employed to determine
the effective NP density of the agglomerates (ρe, g/cm
3),
agglomerate porosity parameter (εagg, unitless), diffusion
rate (D, m2/s), sedimentation velocity (V, m/s), depos-
ition factor, (α, h−1), and the deposition fraction curve
[fD(t)]. Harvard VCM, which utilizes experimental
methods to measure the effective volume of NP pellets
(Vpellet), was employed to estimate the ρe of the NP
agglomerates. To measure the Vpellet, NP suspensions
were prepared at a concentration of 100 μg/ml in nano-
pure water and sonicated with 1.05 W of power for
30 min. The resulting stock dispersions were introduced
to RPMI-based cellular media at a concentration of
1.25 mM and then centrifuged at 2000×g for 1 h in TPP
(Techno Plastic Products, Trasadingen, Switzerland)
packed cell volume tubes, and the resulting NP pellets
were measured utilizing the TPP “easy read” measuring
device by the same manufacturer.
Once the Vpellet for a NP dispersion was measured, the
ρe of the NP agglomerates was then calculated using the
following equation (DeLoid et al.) [32]:
ρe ¼ ρmedia þ
MZnO−MZnOSol
V pelletSF
 
1−
ρmedia
ρZnO
  
ð1Þ
This calculation represents the ρe as a function of the
media density (ρmedia) and density represented by the
NP material. Since ZnO is partially soluble in nanopure
water, the mass of solubilized ZnO (MZnOSol) determined
by ICP-MS as outlined above was subtracted from the
original mass of ZnO (MZnO). A theoretical stacking fac-
tor (SF) of 0.634 to approximate random close stacking
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employed by many dosimetry models [32, 33] was uti-
lized. The density value for ZnO NPs (ρZnO) of 5.606 g/
cm−3 was used. The deposition factor, (α) [43], a func-
tion of the sedimentation velocity (V), diffusion rate (D),
and height of the media in the cell well (L)
α ¼ D
VL
ð2Þ
was then utilized to generate deposition fraction curves
[fD(t)]:
f D tð Þ ¼ 1− e−∝t ð3Þ
and time values needed to observe 90 % deposition of
suspended NPs in solution (t90) [47]:
t ¼ − ln 1−f D tð Þð Þ
∝
ð4Þ
To model dosimetry kinetics for suspension cell
models, the curves representing the fraction of available
NPs [fA(t)] were created using the following equation:
f A tð Þ ¼ e−∝t ð5Þ
To determine the effective density, the in vitro sedi-
mentation, diffusion, and dosimetry (ISDD) computa-
tional model employs the unitless agglomerate porosity
parameter (εagg)
εagg ¼ 1− dHdXRD
 DF−3
ð6Þ
where dH represents the hydrodynamic size, dXRD refers
to the NP crystalline size measured by XRD, and DF is
the specific fractal dimension. A DF value of 2.3, often
employed to model metal oxide suspensions [47], was
used in this study. Once εagg had been calculated, the ρe
was calculated utilizing Eq. 7
ρe ¼ 1−εagg
 
ρZnO þ εaggρmedia ð7Þ
The ρe value was then employed to calculate the sedi-
mentation velocity (V, m/s) via Eq. 8
V ¼ g ρZnO − ρmedia
 
dH
18μ
ð8Þ
with g = 9.8 m/s2 and μ defined as the media viscosity
(Pa · s). Finally, the diffusion rate (D, m2/s) was deter-
mined by
D ¼ RT
3NAπμdH
ð9Þ
where R is the gas constant (L · kPa/K/mol), NA is
Avogadro’s number, and T (K) is the temperature.
Cell Culture and Cytotoxicity Studies
For cell cytotoxicity assays, Jurkat T cell leukemia, Hut-
78 T cell lymphoma, T-47D epithelial mammary gland
carcinoma, and the LNCaP epithelial prostate cancer cell
line (ATCC, Rockville, MD) were cultured in cellular
medium. Additionally, the T-47D media was supple-
mented with 0.2 units/ml bovine insulin. Cells were main-
tained in log phase at 37 °C and 5 % CO2 and seeded at a
concentration of 5 × 105 cells/well in 96-well plates for
Jurkat and Hut-78 cells. For the T-47D and LNCaP cells,
the cells were first trypsinized using 0.25 % trypsin/
0.53 mM EDTA (MP Biomedicals, LLC; Santa Ana, CA),
re-suspended in fresh media, and then seeded at a concen-
tration of 2.5 × 105 cells/well in 24-well plates. The cells
were then incubated overnight to allow the cells to re-
adhere to the plate. Prior to treatment, the growth
medium was gently aspirated from each well and replaced
with 400 μL of fresh medium. Cells were subsequently
treated with freshly sonicated (30-min) NPs reconstituted
in the desired solution. Jurkat cells and Hut-78 cells were
treated with NPs immediately after plating. For example,
for a 2 mg/ml ZnO NP stock dispersion, 3.2 mg of NP
was re-suspended in 1.58 ml of solution medium and son-
icated at 50 W for 30 min. Then working dilutions were
prepared from the NP stock dispersion and added to
200 μl of cell suspensions in 96-well plates or 400 μl of cell
suspensions in 24-well plates and cultured for 24 h. After
24 h, the effects of the various NP stock dispersions on
cell viability were determined using two different viability
assays, alamar blue and flow cytometry. The alamar blue
metabolic assay was employed to assess viability based on
the fluorogenic redox indicator dye resazurin being con-
verted to the fluorescent resofurin upon reduction by
mitochondrial enzymes in metabolically active cells. In
this assay, cell populations were seeded into the desired
plate at the concentrations indicated above, treated with
NPs for 20 h, and then incubated with alamar blue (10 %
of total volume) for an additional 4 h. Changes in fluores-
cence were evaluated spectrophotometrically using excita-
tion/emission at 530/590 nm in a Biotek Synergy MX®
plate reader (Winooski, VT).
Flow cytometry was employed as an alternate viability
assay to verify experimental results. NP-treated cells were
dually stained with a fluorescein isothiocyanate-labeled
anti-HLA ABC antibody and 50 μg/ml propidium iodide
(PI) to monitor losses in membrane integrity. Fluorescent
CountBright counting beads (Invitrogen, Carlsbad, CA)
were added to samples to enable determinations of abso-
lute cell numbers, and changes in PI staining were used to
quantify cell death. Nanoparticles were excluded from
analysis based on the absence of fluorescence signal
and light forward scatter (FS) and side scatter (SSC)
characteristics, and samples were analyzed using a BD
FACS Caliber flow cytometer.
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For CD4+ T cell cytotoxicity experiments, written in-
formed consent was obtained from all blood donors and
the University Institutional Review Board approved this
study. Peripheral blood mononuclear cells were obtained
from healthy human blood samples via Ficoll-Hypaque
density centrifugation (Histopaque-1077, Sigma, St. Louis,
MO) and CD4+ T cells isolated by negative immunomag-
netic selection as previously reported [16]. Purified CD4+
T cells (>95 % purity) were cultured in RPMI/10 % FBS
and suspended at a final concentration of 1 × 106 cells/ml.
CD4+ T cells were then incubated for 24 h with increasing
amounts of each of the nZnO suspensions (24–800 μg/
ml) in order to establish an IC50. CD4
+ T cells were then
stained and viability analyzed by flow cytometry.
Reactive Oxygen Species (ROS) Detection
Mitochondrial superoxide levels were determined by flow
cytometry using MitoSOX Red (Invitrogen, Eugene, OR)
staining. MitoSOX Red is a cell permeable fluorescent dye
that becomes oxidized by interacting with mitochondrial
superoxide [48]. The resulting fluorescent signal occurs
upon binding of the oxidized dye to nucleic acids. As a
positive control, samples were treated with 0.2 nM of the
mitochondrial electron transport inhibitor antimycin-A to
ensure that the cells were capable of producing ROS. Jur-
kat cells were incubated with 0.4 mM nZnO or nZnO-
FBS for 6, 18, and 24 h and then dually stained with CD3
antibody and 2.5 μM MitoSOX Red for 30 min. Mito-
chondrial superoxide levels were determined by flow
cytometry.
Statistical Analyses
Statistical analyses were performed using Jump Pro 10
software (SAS; Cary, NC). The cytotoxicity data were an-
alyzed using repeated measures of variance with post
hoc comparisons and significance levels defined as p <
0.05 to determine statistical differences between the
means and allow within-sample variation to be separated
from between-sample variation. Data for Figs. 10, 11,
and 12 were analyzed using a two-way analysis of vari-
ance (ANOVA) to test for statistical significance of the
model, and post hoc comparisons were used to test for
statistically significant effects of treatment on cell viabil-
ity (p < 0.05) with an asterisk denoting statistical signifi-
cance in the indicated figures.
Results and Discussion
ZnO Nanoparticle Synthesis and Characterization
The pure ZnO NPs (nZnO) and the FBS-coated formu-
lation (nZnO – FBSdried) were thoroughly characterized
prior to use. Analysis of the powder X-ray diffraction
spectra of the NPs revealed the expected hexagonal
wurtzite crystal structure (Fig. 1). The MAUD software,
which employs the Rietveld method [49] showed the
particles had an average crystallite size of 10.0 ± 0.74 nm
and lattice parameters a = 3.2580 Å and c = 5.226 Å. The
nZnO – FBSdried sample also showed similar crystallite
size and lattice parameters suggesting that the FBS coat-
ing did not alter the crystalline structure of the nZnO
nanoparticles. Additionally, TEM analysis confirmed that
the NPs in both formulations were primarily spherical in
morphology with similar size distributions (Fig. 1b, c).
Surface charge for nZnO and the nZnO – FBSdried
NP samples, measured in nanopure water using electro-
phoretic measurements, was found to be 43.8 ± 0.55 mV
and −11.8 ± 0.39 mV, respectively. Bovine serum albumin
(BSA), the predominant component of FBS, has an iso-
electric point (IEP) of 5.1 indicating that BSA would be
positively charged at lower pH (<5.1) and negatively
charged at higher pH values (>5.1) [50]. Therefore, the
positive to negative shift in the zeta potential observed for
the nZnO – FBSdried NPs is indicative of the absorption of
negatively charged protein components on the surface of
the nZnO [51]. To determine the IEP of each NP suspen-
sion, the pH was varied from 3 to 12 using 0.1 M HCl or
0.1 M NaOH and the zeta potential was measured at sev-
eral points in three independent trials (Fig. 2a). An IEP of
9.5 was observed for nZnO indicating these NPs would
carry a positive charge below pH 9.5 and a negative charge
at pH >9.5. In contrast, the nZnO – FBSdried formulation
had an IEP of pH 6.1, resulting in positively charged parti-
cles at much lower pH values (below 6.1) and negatively
charged particles at pH >6.1. Below pH 6.5, partial NP
dissolution was observed for nZnO but not for the
nZnO – FBSdried sample. The decreasing zeta potential
trend observed at low pH values for nZnO has been
documented for nZnO prepared using this synthesis
method [28].
The FTIR spectra of nZnO and nZnO – FBSdried are
shown in Fig. 2b. Both samples contain a strong band
characteristic of Zn-O vibrations [52] at 456 cm−1 (nZnO)
and 451 cm−1 (nZnO – FBSdried). The nZnO sample ex-
hibits two bands commonly associated with the carboxyl
functional group, specifically 1412 cm−1 [νs(COO
−)] and
1597 cm−1 [νas(COO
−)] [53, 54]. Additionally, weaker
bands consistent with τ(CH2) and ν(C–OH) at 903 and
1076 cm−1, respectively, indicate the presence of
surface-adsorbed carboxyl groups originating from the
zinc acetate precursor or the DEG solvent [52–54]. Further-
more, the absence of the ν(C=OOH) band at ~1720 cm−1
suggests that the carboxyl groups are in an expected depro-
tonated form as a result of the alkaline synthesis procedure
[53]. Noticeably absent in the nZnO – FBSdried samples are
the strong symmetric and asymmetric stretching modes of
the carboxyl group with new bands appearing in the
spectrum at 1646 and 1533 cm−1 representing the amide I
and amide II regions that arise from vibrations of the pep-
tide bonds of the protein backbone [55, 56]. The amide I
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region, often used for secondary structure prediction,
exhibits a maximum at 1650–1656 cm−1 when α-helices
predominate in the protein secondary structure [56]. At
1646 cm−1, the amide I band of the nZnO – FBSdried parti-
cles is close to this wavenumber maximum and suggestive
of the presence of a protein with the α-helical structure
components found in BSA. The slight shift of this max-
imum is consistent with a more random secondary struc-
ture (1644–1648 cm−1) and has been observed in protein
adsorption and binding studies with albumin [57]. Taken
together, these findings clearly establish the displacement of
adsorbed carboxyl groups and strong binding of the FBS
protein components [58, 59] on the nanoparticle surface.
Agglomeration and Sedimentation Profiles
As previously discussed, determining the best media com-
ponents and dispersion conditions for the preparation of
stable nZnO dispersions was a major goal of this study. Re-
ported cellular toxicity studies using Jurkat and Hut-78
cells have frequently employed a variety of different bio-
logical solutions used to disperse NP powder samples prior
to treatment. Considerations in choosing stock solution
components include maintaining a viable environment for
the cells as well as creating a stable NP dispersion for treat-
ment conditions. Commonly used stock solutions consist
of nanopure water, PBS, or un-supplemented cellular
media. In addition, various capping agents [60] or protein
components are often utilized to reduce steric attractions
between charged particles and solution components and
reduce NP agglomeration [51, 60, 61]. Solutions such as
PBS or un-supplemented media are generally preferred as
they do not result in unwanted pH changes during the tox-
icity study or affect cellular osmolality. Likewise, media
proteins such as BSA and FBS are frequently used as stabil-
izing agents.
The average hydrodynamic size of the nZnO sample in
six different 25 mM stock dispersions was measured
Fig. 1 Crystal phase composition, size, and morphology characterization for nZnO and nZnO – FBSdried NPs. a XRD spectra and TEM images for
b nZnO and c nZnO – FBSdried
Fig. 2 Surface property analysis for nZnO and nZnO – FBSdried.
a Zeta potentials measured as a function of pH and b FTIR spectra
with the wavenumbers of the main peaks marked
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every 10 min for a 24-h time period using dynamic light
scattering (DLS) technique (Fig. 3a). From this data,
inferences can be made about the agglomeration tenden-
cies of the NPs over time in different biological solution
systems. Two of the solutions, RPMI and PBS, exhibited
unstable average hydrodynamic size profiles over time
evidenced by the immediate formation of very large
agglomerates of 2031 and 3578 nm, respectively. The ag-
glomerate sizes in PBS increased over time from 3578 to
5811 nm and eventually stabilized to a variable range of
2500–4200 nm over the remaining test period. In RPMI,
the nZnO agglomerate size increased dramatically over
time from 2031 nm to sizes exceeding the limits of the
Zetasizer (~10,000 nm) by the end of the time period.
These data indicate that agglomeration behavior of NP
systems increases with increasing ionic strength of the
dispersion solution (nanopure water < PBS < RPMI). All
other test dispersions exhibit stable average hydrodynamic
size profiles over time with average size profiles of 306 nm
(nanopure water), 150–200 nm (DMEM-based cellular
media), 263 nm (RPMI-based cellular media), and 78 nm
(FBS). To evaluate the effect of FBS on dispersion stability,
all three nZnO/FBS formulations, nZnO – FBSdried (dried
FBS-coated nZnO), nZnO – FBSwashed (FBS-coated nZnO
with excess FBS removed), and nZnO – FBS (nZnO
coated with 10 % FBS per volume of desired solution),
were dispersed in both PBS and nanopure water at con-
centrations of 25 mM. For PBS stock dispersions, the FBS
coating provided long-term hydrodynamic size stability
(up to ~15 h) regardless of the formulation employed
when compared to the nZnO/PBS dispersion (Fig. 3b).
Beyond 15 h, the nZnO – FBSdried/PBS dispersions dem-
onstrated some instability in agglomeration behavior with
average agglomerate sizes increasing from approximately
400 to 800 nm. The addition of FBS in nanopure water
dispersions did not appreciably change the agglomerate
stability of the NP suspensions. Relatively stable agglomer-
ation profiles were observed between ~200 and 350 nm
for all dispersions (Fig. 3c). Interestingly, the nZnO –
FBSdried formulation also displayed a mild degree of dis-
persion instability at ~13 h. These findings, along with
those for the PBS-based suspension, suggest that the
nZnO – FBSdried formulation is not the most ideal prepar-
ation for downstream applications which require long-
term dispersion stability.
Although average size profiles highlight the agglomer-
ation tendencies of NP dispersions, they fail to depict how
agglomerate formation affects NP sedimentation, changes
in the net nZnO concentration in the solution over time,
and the ever-changing size distribution of a complex NP
dispersion. To address these shortcomings, experiments
evaluating the sedimentation behavior of nZnO disper-
sions were performed by measuring changes in the optical
absorbance intensity at λmax (~378 nm corresponding to
Fig. 3 Aggregation profile evaluation for NP stock dispersions.
Average hydrodynamic size profiles of 25 mM ZnO stock dispersions
(pH = 7.3) for a 24-h time period. a nZnO in various biologically
relevant solutions. b nZnO, nZnO – FBSdried, nZnO – FBSwashed, and
nZnO – FBS stock dispersions in PBS and c nZnO, nZnO – FBSdried,
nZnO – FBSwashed, and nZnO – FBS stock dispersions in nanopure water
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the band gap energy of nZnO) relative to the initial
absorbance intensity. Decreases in the relative absorbance
intensity at λmax as a function of time have been correlated
to decreasing NP concentrations in the solution as a result
of NP sedimentation [23, 62]. The sedimentation tenden-
cies over a 2-h time period for various stock dispersions
are depicted in Fig. 4a. As expected, nZnO in RPMI rap-
idly settles out of the solution with 100 % sedimentation
noted by the 1-h time point. Other dispersions that dis-
played sedimentation behavior were nZnO dispersions in
both RPMI-based cellular media (29 % at 2 h) and PBS
(49 % at 2 h). None of the nZnO – FBS formulations
(nZnO – FBSdried, nZnO – FBSwashed, or nZnO – FBS)
showed any appreciable sedimentation behavior over the
2-h time period in PBS or nanopure water (Fig. 4a, b).
Further evidence of NP dispersion stability can be
observed in the hydrodynamic size distribution profiles at
various time intervals (Figs. 5, 6, and 7). Stable dispersions,
such as those observed for the nanopure water (Fig. 5a),
demonstrate similar size distribution trends across the
evaluated time period. Strong agglomeration and sedi-
mentation tendencies result in broader distributions ini-
tially as a result of immediate agglomerate formation,
followed by narrower distributions as large agglomerates
settle out of the dispersion. This trend is readily apparent
for the PBS dispersion (Fig. 5b) and present to a lesser de-
gree for the cellular media stock (Fig. 5c) which reflects
the improved stability of the nZnO in RPMI-based cellular
media, containing 10 % FBS, compared to the PBS stock.
The size distribution trends observed for the nZnO –
FBSdried, nZnO – FBSwashed, and nZnO – FBS dispersions
in PBS (Fig. 6) and water (Fig. 7) affirm the findings previ-
ously observed. Both the nZnO – FBSdried/PBS (Fig. 6a)
and nZnO – FBSdried/water (Fig. 7a) dispersions begin to
show dispersion instability at ~12 h which is readily
apparent by 24 h. Taken together, the agglomeration pro-
files obtained from DLS and the sedimentation trends
observed by UV-Vis spectrophotometry provide an accur-
ate qualitative assessment of the NP dispersion stability.
After evaluating several stock dispersions independ-
ently, the behavior of the NPs was assessed under condi-
tions used for cellular toxicity assays. In short, aliquots
of the 25 mM nZnO/PBS and nZnO – FBS/PBS stock
dispersions were introduced to RPMI-based cellular
media at concentrations of 0.6 mM and the agglomer-
ation and sedimentation tendencies of the NPs were
observed for 24 h (Fig. 8). Analysis of the data collected
under in vitro experimental conditions reveal that NPs
dispersed in nZnO/PBS display strong agglomeration
potential in the cellular media compared to those pre-
pared using the nZnO – FBS/PBS stock. NPs in the
dispersion prepared using the PBS stock formed large
agglomerates immediately (>500 nm) (Fig. 8a, c), which
precipitated rapidly from the cellular media (Fig. 8b),
reducing the percent intensity and changing the max-
imum in the agglomerate size distribution (Fig. 8c). At
the 12-h time point, the hydrodynamic size profile
revealed a large distribution of NP sizes present within
the solution with a 54 % decrease in the nZnO absorb-
ance. Significant decreases in the hydrodynamic size dis-
tribution can be seen by the 24-h time point suggesting
that large agglomerates had precipitated from the cellu-
lar media (Fig. 8a, c). The sedimentation profile (Fig. 8b)
confirms that by 24 h nearly 60 % of the nZnO was no
longer present in the cellular media. Comparatively, the
experimental dispersion (0.6 mM) prepared from the
nZnO – FBS/PBS stock exhibited considerably more size
stability over time (Fig. 8a, d) resulting in less sedimen-
tation behavior (39 %) by 24 h (Fig. 8b). In the context
of in vitro cytotoxicity studies, these results imply that
Fig. 4 Sedimentation profile evaluation for NP stock dispersions.
Sedimentation profiles of 25 mM ZnO stock dispersions (pH = 7.3)
for a 2-h time period. a nZnO, nZnO – FBSdried, nZnO – FBSwashed,
and nZnO – FBS stock dispersions in various biologically relevant
solutions. b Sedimentation histograms for 0, 0.5, 1.0, 1.5, and 2.0-h
time points for nZnO – FBSdried, nZnO – FBSwashed, and nZnO – FBS
stock dispersions in PBS and nanopure water
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using FBS as a NP stabilizing agent prior to solution dis-
persion results in more NPs being bioavailable to interact
with cells cultured in suspension. Although most of the
ZnO NPs are in the 100–250 nm range at the 24-h time
point, there are some significantly large agglomerates
(3000–6000 nm) in the hydrodynamic size profiles (inset
in Fig. 8d) of nZnO – FBS samples. However, their percent
abundance is <5 % of the total number of observed aggre-
gates at 24 h.
Dissolution Studies
Experiments were conducted to investigate if Zn2+ ions
are released from the ZnO NP, when dispersed in stock
solutions prepared at concentrations typically employed
for downstream biological assays (6 mM of nZnO). Zn2+
dissolution was measured using a PBS stock dispersion
and compared to the same after adding 10 % FBS to
improve dispersion stability. Figure 9 shows the Zn2+
dissolution data (displayed as percentage of the total
Fig. 5 Hydrodynamic size distribution profiles at 0, 12, and 24 h. Histograms represent 25 mM stock dispersions prepared in a nanopure water,
b PBS, and c RPMI-based cellular media
Fig. 6 Hydrodynamic size distribution profiles at 0, 12, and 24 h. Histograms represent 25 mM stock dispersions prepared in PBS for a nZnO – FBSdried,
b nZnO – FBSwashed, and c nZnO – FBS
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nZnO concentration in each solution as a function of
time). Among these, the nZnO – FBS/PBS stock disper-
sion showed the highest Zn2+ dissolution (0.151 ±
0.029 % at 24 h) while the nZnO/PBS stock (0.033 ±
0.004 % at 24 h) showed significantly less Zn2+ ion
release. These dissolution studies were then extended to
samples prepared under actual experimental conditions
(0.6 mM nZnO) used for the in vitro toxicity assay stud-
ies as previously described. This lowering of the nZnO
concentration by 10-fold caused significant increases in
percentage Zn2+ dissolution for both dispersion combina-
tions, as shown in Fig. 9. Decreasing nZnO concentration
in solution will decrease NP agglomeration tendencies
and subsequently increase the interaction of the nanopar-
ticles with the medium, resulting in more Zn2+ ion forma-
tion in the dispersion [63]. Interestingly, the FBS/PBS
sample showed lower Zn2+ dissolution (8.668 ± 0.247 % at
24 h) than the pure PBS sample (10.041 ± 2.905 % at
24 h). Since FBS addition increases dispersion stability and
reduces hydrodynamic size, an increase in the Zn2+ dissol-
ution is expected if interaction of the NPs with the dis-
persed medium alone is the most important factor. The
observed lower Zn2+ dissolution of the nZnO – FBS/PBS
sample may be due to the presence of serum proteins
from FBS on the nZnO surface, reducing direct NP-media
interaction and thus protecting them from Zn2+ dissol-
ution. Both FTIR and zeta potential measurements have
shown that 10 % FBS addition produces a surface layer
of serum proteins on the nZnO surface. Thus, the
lower Zn2+ dissolution of nZnO – FBS/PBS dispersion
(0.6 mM) is likely attributed to the serum coating of the
nZnO and the resulting reduction in the NP-medium in-
teractions. Another potential contributing factor in these
systems is the propensity of free zinc ions to form insoluble
zinc carbonate (ZnCO3) or zinc phosphate (Zn3(PO4)2)
precipitates in biologically relevant solutions [61, 64]. Pre-
cipitation of these species may explain dissolution potential
differences between the prepared nZnO/PBS and nZnO –
FBS/PBS stock dispersions given the assumption that the
FBS present in suspension may provide a protective func-
tion against nZnO and Zn2+/media interactions, thus redu-
cing the amount of insoluble complexes formed and
increasing the concentration of ionic Zn2+ [65]. However,
if this were the sole contributing factor, the same dissol-
ution pattern would be expected when the stock disper-
sions were introduced into the cellular media. The reversal
of the dissolution potential trend going into the cellular
media underscores the complex nature of nZnO dissol-
ution in biologically relevant solutions. While our results
appear to contradict a recent study by Hsiao and Huang
[41] in which a much larger Zn2+ dissolution was observed
when FBS-coated ZnO NPs were dispersed in DMEM
media, these apparent discrepancies may be attributable to
solution-related dissolution differences. Additional studies
conducted in our laboratory have shown that nZnO dis-
persed in the RPMI-based cellular media employed in this
study exhibit significantly less dissolution potential than
nZnO dispersed in the DMEM used by Hsiao and Huang
(data not shown). The decrease in ionic zinc in the RPMI-
based media compared to DMEM could be attributed to
increased precipitation of insoluble Zn3(PO4)2 in the
phosphate-rich RPMI system [61, 65]. Furthermore, NP
Fig. 7 Hydrodynamic size distribution profiles at 0, 12, and 24 h. Histograms represent 25 mM stock dispersions prepared in water for a nZnO – FBSdried,
b nZnO – FBSwashed, and c nZnO – FBS
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dissolution in the presence of serum proteins appears
to be a competition between two processes. Serum pro-
teins reduce agglomerate size allowing more interaction
between NP surface and the dispersing medium. How-
ever, serum proteins will also attach to the nanocrystal
surface effectively reducing the interaction of surface
bound Zn ions and the medium.
Reactive Oxygen Species
The potential role of intracellular reactive oxygen species
(ROS) generation in the cytotoxicity of nZnO was dem-
onstrated in our earlier reports [10, 15, 16] and through
several other studies for a variety of cells types [66–68]
by using fluorescent dyes to directly detect ROS. Since
redox reactions at the NP surface are a primary driver in
Fig. 8 Dispersion stability analysis for nZnO/PBS and nZnO – FBS/PBS stock solutions introduced to RPMI-based cellular media at a concentration of
0.6 mM. a Average hydrodynamic size profiles for a 24-h time period. b Sedimentation profiles for a 24-h time period. Hydrodynamic size distribution
profiles at 0, 12, and 24 h for c nZnO/PBS stock dispersion in RPMI-based cellular media and d nZnO – FBS/PBS stock dispersion in RPMI-based
cellular media
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extracellular and intracellular ROS production, changes
in the NP surface structure as a result of protein coating
could change ROS generation and, in turn, also influ-
ence the cytotoxicity. To evaluate the amount of ROS
produced by nZnO and nZnO – FBS, Jurkat cells were
exposed to 0.4 mM ZnO for 6, 18, and 24 h and subse-
quently stained with MitoSOX Red. As Fig. 10 illus-
trates, appreciable differences exist between the amounts
of ROS produced at 6 h (Fig. 10a, b), as measured by
the mean MitoSOX fluorescence intensity (MFI), be-
tween the nZnO dispersion (PBS stock; 33.9 ± 2.66
MFI) versus the nZnO – FBS dispersion (FBS/PBS
stock; 49.9 ± 4.98 MFI) representing a 47.2 % increase
in the amount of NP-induced ROS present in cells
treated with the nZnO – FBS dispersion. As the ex-
posure time increases, the differences in the ROS pro-
duction increase significantly. The greatest disparity,
noted at 24 h (Fig. 10a, d), represents an 88.2 % in-
crease in the amount of ROS induced by the nZnO –
FBS over the nZnO dispersion. Given that the ag-
glomerates present in the nZnO – FBS dispersion are
significantly smaller and more bioavailable than those
in the nZnO dispersion, more surface area to volume
interactions are possible in the more stable nZnO-
FBS which could result in the significant differences
observed in the ROS induction. While many surface
modifications, such as SiO2 coating, have demon-
strated protective benefits such as less cytotoxicity
and cellular stress-inducing ROS production [42, 66],
FBS coating does not appear to impart protective
benefits against ROS generation.
Cellular Toxicity Studies
It has been previously shown in our laboratory that
these nZnO synthesized in DEG media demonstrate
strong cytotoxic effects against Jurkat leukemic and Hut-
78 lymphoma T cell cancer lines [16]. Experiments were
performed to determine if FBS coating and the resulting
improvements in NP stability and bioavailability influ-
ence the cytotoxicity of NPs in these suspension cell
models. Cells were exposed to increasing concentrations
of freshly prepared nZnO/PBS or nZnO – FBS/PBS
stock dispersions for 24 h. NP-induced toxicity was then
determined using an alamar blue assay or through flow
cytometry utilizing a T cell-specific fluorescent antibody
and propidium iodide (PI) dye uptake [16]. As shown in
Fig. 11, both types of cancer cells showed a significant
increase in the NP-induced cytotoxicity (p = 0.0022 and
p = 0.0488 for Jurkat and Hut-78 cells, respectively)
when nZnO – FBS/PBS stock-treated cultures were
employed, thus confirming the favorable role of 10 %
FBS addition in the stock dispersion preparation. The
IC50 values for Jurkat cells decreased from 0.39 ±
0.03 mM for nZnO/PBS dispersions to 0.27 ± 0.02 mM
for the nZnO – FBS/PBS dispersion using alamar blue
staining (Fig. 11a) and from 0.38 ± 0.03 mM for
uncoated nZnO to 0.25 ± 0.004 mM for nZnO – FBS
using flow cytometry and PI uptake (Fig. 11b). Similarly,
the IC50 value for the Hut cells (Fig. 11c) also showed a
decrease from 0.21 ± 0.03 mM when treated with the
nZnO/PBS dispersion to 0.14 ± 0.02 mM when treated
with the nZnO – FBS/PBS dispersion. These results
clearly demonstrate that coating nZnO with FBS pro-
teins and the resulting improved dispersion stability
increases their toxic response to cancer cells by ~33 %
for both cell types. Additionally, FBS coatings may also
provide a potential approach to reduce the IC50 values
of nZnO against cancer cells from their current millimo-
lar range to more suitable ranges appropriate for thera-
peutic applications.
Our previous work has shown that ZnO NPs display
some selectivity in their toxic response against cancerous
T cells as the IC50 values observed for primary quiescent
T cells under similar conditions are considerably higher.
Similar toxicity studies using nZnO – FBS/PBS disper-
sions also showed stronger toxic responses (p = 0.0303) to
resting CD4+ T lymphocytes (Fig. 11d). Here, the IC50
values decreased from 4.69 ± 0.85 mM when treated with
nZnO/PBS dispersion to 2.43 ± 0.0.24 mM when nZnO –
FBS/PBS dispersions were used. Thus, the effect of coating
NP with serum proteins is evident in primary cells as well.
While these results are consistent with our previously re-
ported preferential cytotoxicity of nZnO to cancer cells,
the therapeutic index of Hut cancer cells decreased from
22.6 for nZnO/PBS dispersions to 17.0 for the nZnO –
FBS/PBS dispersion. Even with the modest decrease noted
Fig. 9 Extracellular dissolution of 6 mM nZnO/PBS and nZnO – FBS/
PBS stock dispersions and 0.6 mM of those respective nZnO stock
dispersions in RPMI-based cellular media. Zn2+ concentration is expressed
as % Zn2+ (total dissolved Zn2+ measured by ICP-MS/total Zn2+ in
sample) to normalize for concentration
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in the therapeutic index for the nZnO – FBS/PBS disper-
sion, the resulting therapeutic efficiency of the nZnO ap-
pears better than some commonly recognized traditional
chemotherapeutic agents using comparable in vitro assays
[16]. Thus, the protein interaction with nZnO increases
their cytotoxicity in the suspension cell models evaluated,
yet maintains some of the cancer cell selectivity previously
observed.
Some published studies have reported that coating
nZnO with organic molecules or media protein compo-
nents results in decreased cytotoxicity and ROS accumu-
lation compared to uncoated nZnO [25, 38, 40–42, 69].
While these studies appear to contradict our findings, it
should be noted that most of these reports evaluated
adherent cells while the primary T cells and cancerous
counterparts employed here are all grow as suspension
cultures. In adherent cell cultures, poor dispersion sta-
bility results in faster sedimentation of NP agglomerates
onto the cell monolayer. This rapid sedimentation may
artificially lead to higher increases in NP-cell interactions
[34] and the observed increased toxicity [39, 41, 42].
When the dispersion stability improves and sedimentation
decreases with the addition of suitable molecules such as
FBS, adherent cells will be exposed to lesser amounts of
deposited NPs resulting in more accurate dosimetry
kinetics, measured effective administered doses, and
observed toxicity values, as reported by many recent
studies [25, 38, 40–42, 69]. This possibility was con-
firmed by comparing the effects of nZnO/PBS and
nZnO – FBS/PBS dispersions in two different adherent
Fig. 10 Cellular production of ROS following ZnO NP exposure. ROS generation was evaluated in Jurkat cells at 6, 18, and 24 h following treatment with
nZnO/PBS (PBS) and nZnO – FBS/PBS (FBS/PBS) stock dispersions using MitoSOX red and flow cytometry (means ± standard error, minimum of n= 3). Cells
were treated with 0.4 mM nZnO and stained with MitoSOX red and CD3 antibody after the desired time. a Mean MitoSOX fluorescence intensity for a
non-treated control (NT) and nZnO and nZnO – FBS exposure. To assess relative increases in ROS following NP treatment, a marker (M1) was set so that
background fluorescent in control samples (MitoSOX loaded/no NP) was between 1 and 3.5 %. Histograms represent b 6 h, c 18 h, and d 24 h
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epithelial cancer cell lines, T-47D mammary gland car-
cinoma and LNCaP prostate cancer cell lines (Fig. 12).
For both adherent cell lines, the nZnO – FBS/PBS-
treated cells exhibited less toxicity when compared to
the nZnO/PBS-treated cells (p = 0.0020 and p = 0.0008
for the T-47D and LNCaP cells, respectively). For the
T-47D (Fig. 12a) cells, a 48.7 % increase in the IC50 was
observed for the nZnO – FBS/PBS dispersions over the
nZnO/PBS-treated cells (from 0.39 ± 0.02 mM for
nZnO/PBS to 0.58 ± 0.01 mM for nZnO – FBS). Com-
paratively, the IC50 for the LNCaP cells (Fig. 12b)
increased from 0.35 ± 0.02 mM nZnO/PBS-treated cells
to 0.60 ± 0.06 mM for nZnO – FBS/PBS-treated cells
representing a 71.4 % decrease in the toxic response.
In comparison to the suspension cell models, FBS
coating leads to opposite effects in adherent cells. Sus-
pension cells interact with fewer NPs in experimental
conditions consisting of even minimally unstable disper-
sions since a portion of the original NP concentration
sediments and may not be bioavailable for cellular inter-
actions. This will skew toxicity assay results to suggest
lower toxicity for suspension cells than expected. When
the stability of the NP dispersion is improved by suitable
molecular additives such as 10 % FBS (Fig. 11), the cyto-
toxicity increases significantly for both Jurkat and Hut
cancer cells as well as for the primary T cell lympho-
cytes. More ZnO NPs are freely available in the stable
NP dispersions to interact with more cells, thus resulting
Fig. 11 ZnO NP toxicity using nZnO/PBS and nZnO – FBS/PBS stock dispersions for 24 h on various suspension cell types. Cultures were treated
concurrently with varying concentrations of ZnO NP for 24 h and cell viability was evaluated (means ± standard error, minimum of n = 3).
Statistical analysis was performed using repeated measures analysis of variance and model-based means post hoc test (p < 0.05) with an asterisk
denoting statistical significance. Jurkat cell viability was assessed using both a alamar blue staining or b flow cytometry and PI uptake to evaluate
between assay variability and repeatability. c Hut-78 cell viability using alamar blue staining and d CD4+ T cell viability using flow cytometry and
PI uptake
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in the higher cytotoxicity observed in suspension cell
models. The stability-induced differences between sus-
pension and adherent cells underscore the importance
of this work. The results from suspension cell studies
alone would seem surprising considering other reports
employing similar serum coatings describe decreases in
NP-induced cytotoxicity in adherent cell lines suggesting
that NP coating could be a potential means to control
unwanted cytotoxicity [39]. One such study, Hsiao and
Huang [41], demonstrated that 5–10 % FBS coating on
ZnO NPs increased dispersion stability and Zn2+ ion
release, and decreased the NP-induced cytotoxicity. They
hypothesized that this reduction in cytotoxicity in the
serum-coated NPs was a result of serum-induced in-
creases in cell growth and resulting decreases in nZnO
dosage-per-cell ratios. Additionally, these authors [41]
showed larger Zn2+ release in their experiments with
FBS-coated ZnO thus negating Zn2+ release as a primary
contributing mechanism to nZnO cytotoxicity. In this
present study, FBS coating appears to decrease the Zn2+
release while significantly increasing NP-induced cyto-
toxicity for the suspension cell model when compared to
uncoated nZnO. With the addition of the 10 % FBS to
our phosphate-rich stock dispersion, it is plausible that
decreases in formation of toxic insoluble Zn3(PO4)2 pre-
cipitates [70] could translate to perceptible decreases in
the NP-induced cytotoxicity observed for nZnO – FBS/
PBS treatment. However, decreases in Zn3(PO4)2 forma-
tion would also result in measured increases in Zn2+
release which was not observed. Therefore, extracellular
Zn2+ dissolution is unlikely to be a primary factor for
the increased cytotoxicity noted for our nZnO – FBS
NPs. It is clear from FTIR and zeta potential studies that
FBS molecules bind to the ZnO NP surface. This modifi-
cation of the NP surface influences their interaction with
other NPs (and on agglomerate formation and sedimen-
tation effects) as well as with cells.
Modeling and Dosimetry Studies
Given the toxicity trend differences noted for the differ-
ing cell models, mathematical models were investigated
as a potential method to confirm the observed trends
and to model the dosimetry kinetics for both the investi-
gated stock dispersions (nZnO/PBS versus nZnO – FBS/
PBS) and the different cellular models. All of the investi-
gated experimental parameters of dispersion stability can
be applied to the in vitro sedimentation, diffusion, and
dosimetry (ISDD) computational models, put forth by
Hinderliter et al. (2010), to predict the transport proper-
ties of the NPs in various experimental conditions [43].
The NP and experimental parameters which most influ-
ence the NP transport properties include hydrodynamic
size (dH), agglomeration state, effective particle density
(ρe), and the media height in the cell well (L) [43]. Cen-
tral to the effective dosimetry determination in the ISDD
model is the calculation of a NP deposition factor α (h−1),
Eq. 2 in “Experimental Details”, which interrelates the diffu-
sion rate (D), sedimentation velocity (V), and media height
[32, 33, 43, 44]. While the diffusion rate is primarily
dependent upon the hydrodynamic size, the sedimentation
velocity depends upon both the hydrodynamic size and the
effective particle density occupied by NP agglomerates [43,
44]. The effective particle density (ρe) can be approximated
in the ISDD model (Eq. 7) using the hydrodynamic size-
dependent agglomerate porosity parameter (εagg) [43] or
can be determined experimentally (Eq. 1) as a part of the
Harvard Volume Centrifugation Method (VCM) [33, 43].
The Harvard VCM employs an experimental determination
of NP agglomerate volumes to directly determine effective
Fig. 12 ZnO NP toxicity using varying concentrations of nZnO/PBS
and nZnO – FBS/PBS stock dispersions for 24 h on adherent cell
types. a T-47D epithelial mammary gland carcinoma and b LNCaP
epithelial prostate cancer cells. Cultures were treated concurrently
and cell viability was evaluated (means ± standard error, minimum of
n = 3). Statistical analysis was performed using repeated measures
analysis of variance and model-based means post hoc test (p < 0.05)
with an asterisk denoting statistical significance
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particle density. Furthermore, the VCM has been modified
to incorporate mass lost due to the dissolution of soluble or
partially soluble NPs such as ZnO [32, 33].
To determine dosimetry curves for various experimen-
tal conditions, 25 mM dispersions were prepared and
dispersed in complete cellular media at a concentration
of 1.25 mM and the effective density (ρe) determined
using Harvard VCM (Table 1) [33]. From the calculated
deposition factor, α (h−1), dosimetry curves were con-
structed (Fig. 13) as described in Cohen et al. (2014)
[33]. Originally introduced as a model for adherent cell
culture, the deposition fraction curve [fD(t)] (Eq. 3;
Fig. 13a) depicts the fraction of NPs that are deposited
upon an adherent cell layer as a function of time [32,
33]. However, the same α values may be used to model
the fraction of NPs that remain bioavailable [fA(t)] as a
function of time for suspension cells (Eq. 5; Fig. 13b).
Based on these curves, a t90 value can be calculated to
make accurate determinations of effective NP dose either
deposited on an adherent cell layer or bioavailable to sus-
pension cells at desired time points.
The influence of FBS on the dosimetry kinetics is evi-
dent in an analysis of the experimentally stable water,
FBS/water, and FBS stock dispersions introduced to the
RPMI-based cellular media. Given the dependence of
agglomerate behavior and effective density (ρe) on the
hydrodynamic size of NPs in dispersion, the water
(182.5 nm), FBS/water (185.1 nm), and FBS (185.5 nm)
stock dispersions should exhibit similar dosimetry kinet-
ics. However, the effective density (ρe) of the NPs in the
three dispersions decreased with increasing amounts of
FBS in the stock preparation thus increasing the calcu-
lated deposition factor. These disparities are a direct
result of measured increases in the effective volume of
the NP pellet with increasing amounts of FBS in solu-
tion. So while the similarities in the hydrodynamic diam-
eters of these three dispersions imply consistent NP
diffusion rates (Eq. 9), the differing effective volume
measurements suggest different NP sedimentation
velocities (Eq. 8) [32]. Therefore, even though all three
dispersions demonstrate dispersion stability experimen-
tally, the effective volume occupied by the resulting
protein corona in the NP agglomerates decreases the
sedimentation velocities of the NPs predicted by the
model, thus increasing the deposition factor and shifting
the dosimetry kinetics.
Interestingly, the dose metrics obtained for the unstable
stock dispersions of PBS and RPMI suggest dosimetry
trends opposite to what would be expected considering
the experimentally determined agglomeration and sedi-
mentation profiles. However, the VCM dosimetry model
assumes that the dispersions used to obtain the experi-
mental α values are stable across the time frames defined
by the model. As this is not the case with the PBS and
RPMI stock dispersions, these obtained dosimetry curves
cannot be used to accurately model the dosimetry kinetics
under these conditions. To model potentially unstable
dispersions, it is necessary to calculate α values using
experimentally determined stability parameters such as
hydrodynamic size at multiple time points. For this, we
employed the ISDD model. This model approximates
effective particle density utilizing the hydrodynamic
size-dependent parameter εagg. While the approxima-
tion of the ρe employed in this model lacks the experi-
mental accuracy achieved for ρe measurements afforded
by VCM, the ISDD model does allow for time-resolved
approximation of NP transport parameters within un-
stable dispersions. Employing the ISDD model, α values
were obtained using time-resolved dH values and the
dosimetry curves for both the nZnO/PBS and nZnO –
FBS/PBS stock dispersions in RPMI-based cellular
media were modeled for several time points from 0 to
24 h. These time-resolved points were compiled to gen-
erate ISDD curves which were then fit to both the fD(t)
Table 1 Delivered dose metrics
Stock
dispersion in
complete RPMI
Zeta
potential
(mV)
dH (nm) ρe (g/cm
3) 96-well plate 24-well plate
(L = 6.6 mm) (L = 2.25 mm)
α (h−1) t90 (h) α (h−1) t90 (h)
Water −16.1 ± 1.45 182.5 2.021 0.1453 15.6 0.4261 5.4
FBS/Water −15.1 ± 0.81 185.1 1.692 0.2085 11.1 0.6116 3.8
FBS −13.9 ± 0.40 185.5 1.464 0.3121 7.4 0.9154 2.5
PBS −8.1 ± 1.93 663 1.879 0.0087 264.9 0.0255 90.3
FBS/PBS −9.8 ± 2.08 322 1.743 0.0543 42.4 0.1593 14.5
RPMI −14.7 ± 1.46 770.5 1.623 0.0087 263.8 0.0256 89.9
Complete RPMI −13.6 ± 2.63 244.4 1.682 0.1116 20.6 0.3273 7.1
Delivered dose metrics: ρe is the agglomerate effective density (g/cm
3); dH is the hydrodynamic diameter (nm); L is the media height; α is the deposition fraction
(h−1); t90 is the time required for delivery of 90 % of administered dose (h); and α (h
−1) and t90 (h) values are designated for each well plate employed (96-well
plate for suspension cells and 24-well plate for adherent cells)
FBS fetal bovine serum, PBS phosphate buffered saline, RPMI Roswell Park Memorial Institute medium
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and fA(t) mathematical models to obtain α values for
each representative graph (Fig. 13c, d).
For the unstable nZnO/PBS stock, the ISDD α values
of 0.290 for adherent cell model conditions and 0.120
for the suspension cell models were significantly higher
(1037 and 1279 % increases for adherent and suspension
cell models, respectively) than those obtained using the
Harvard VCM (Table 1). The ISDD modeled t90 values
of 7.94 (adherent cells) and 19.12 (suspension cells) were
more consistent with the experimental stability data dis-
cussed earlier. Applying the same model to the stable
nZnO – FBS/PBS stock dispersion, yielded α values
(0.331 and 0.107 for adherent and suspension cell
models, respectively) more closely aligned to the VCM
determined values (Table 1) with percent increases of
107 and 97 % for adherent and suspension cell models,
respectively. Surprisingly, the ISDD modeled curves for
the nZnO/PBS (unstable) and nZnO – FBS/PBS (stable)
dispersions imply similar dosimetry kinetics for both cel-
lular models and, if considered without experimentally
derived stability profiles (e.g., average hydrodynamic size
profiles, size distribution histograms, and sedimentation
analysis), would not reflect the true dosimetry for unstable
stock dispersions. While the ISDD-derived fD(t) curve for
the unstable nZnO/PBS stock dispersion (Fig. 13c) at face
value implies stable dosimetry kinetics, the individual
ISDD curves at each time point reflect the unstable nature
of the nZnO/PBS dispersion (Fig. 14a). As a result, using
either mathematical model to predict the effective dose
for this dispersion would not be advisable. For the stable
Fig. 13 Dosimetry curves for various stock dispersions introduced to RPMI-based cellular media at a concentration of 1.25 mM. a Curves constructed
using α values calculated for 24-well plates and representing the fraction of NP deposited [fD(t)] to an adherent cell as a function of time. b Curves
constructed using α values calculated for 96-well plates and representing the fraction of NPs available [fA(t)] to cells grown in suspension as a function
of time. Dosimetry curves constructed using both the Harvard VCM and ISDD models for both the nZnO/PBS and nZnO – FBS/PBS stocks representing
c NP deposition [fD(t)] and d NP availability [fA(t)]
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nZnO – FBS/PBS dispersion, both the VCM and ISDD
models (Figs. 13 and 14b) depict stable dosimetry kinetics
for both suspension and adherent cell models. For adher-
ent cells, the t90 value of 14.5 h (Table 1; VCM) suggests
90 % of the NPs in suspension will come in contact with
and potentially interact with the cell layer by the 24-h time
point indicating that the experimentally observed toxicity
values are an accurate assessment of the in vitro toxicity
for adherent cell types. Mathematical models for stable
dispersions in suspension cells may provide less definitive
information regarding effective dose. While these models
can accurately predict the amount of NPs remaining in
dispersion as a function of time [fA(t)], the models fail to
account for NP-cellular interactions that will occur within
the suspension culture before sedimentation processes
remove NPs from the dispersion. Better mathematical
models are needed to predict the fate and transport of
NPs in suspension cell models that include NP sedimenta-
tion rates as well as time-resolved NP-cellular interactions.
Taken together, these observations underscore the
importance of time-dependent stability studies for NP
stock dispersions prior to the implementation of fate
and transport dosimetry models and downstream ex-
perimental applications.
Conclusions
Studies reported in this work show that ZnO nanoparti-
cles form very large agglomerates with hydrodynamic
sizes in the 300 to 20,000 nm range which and depend
primarily on the solution composition used. Presence of
such agglomerates leads to sedimentation of a significant
portion of the nanoparticles which increases in time. For
adherent cells, this will increase the effective NP concen-
tration interacting with the cells at very early time points
and may cause unusually large and potentially inaccurate
in vitro toxicity measurements. This was demonstrated
using two adherent epithelial cell lines (T-47D and
LNCaP) with both cell types experiencing significant
decreases in NP-mediated cell death with the more
stable NP stock dispersions. Likewise, this sedimentation
process will reduce the effective NP concentration
remaining in the solution medium. Subsequent investiga-
tions using suspension cells showed that this phenomenon
results in an opposite trend due to the reduction in the
number of nanocrystals interacting with the suspension
cells and, consequently, a lower than actual toxic response
is obtained. Using a 10 % FBS/PBS stock to disperse the
same nZnO, the IC50 values for Jurkat (Hut) cancer cells
decreased from 0.39 mM (0.21 mM) for nZnO/PBS-
treated cells to 0.27 mM (0.14 mM) for the nZnO – FBS/
PBS dispersion. Their normal counterparts (CD4+ T lym-
phocytes) also showed a reduction in IC50 with 10 % FBS
addition. Its IC50 decreased from 4.69 mM for nZnO/PBS
dispersions to 2.43 mM when nZnO – FBS/PBS stock was
used. On the other hand, treating the adherent cells T-
47D and LNCaP using the nZnO – FBS/PBS dispersion
resulted in 48.7 and 71.4 % reductions, respectively, in the
NP-induced toxic response compared to nZnO/PBS dis-
persion. Surface modification of these nZnO using serum
proteins seems to be a suitable approach to obtain stable
dispersions and accurate cytotoxicity values, thus improv-
ing their utility in therapeutic applications.
This study has shown the important role of serum pro-
teins in modifying the ZnO nanocrystal surface resulting
Fig. 14 Dosimetry curves constructed using both the Harvard VCM and ISDD models for nZnO/PBS and nZnO – FBS/PBS stock dispersions introduced
to RPMI-based cellular media at a concentration of 1.25 mM. Curves were constructed using α values calculated for 24-well plates at various time points
(ISDD) and Harvard VCM α values (Table 1). These curves represent the fraction of NPs deposited [fD(t)] to an adherent cell layer as a function of time
for a nZnO – PBS stock dispersions and b nZnO – FBS/PBS stock dispersions
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in the formation of considerably smaller agglomerates and
stable NP dispersions. Furthermore, these FBS surface
coatings influenced Zn2+ release from the nanocrystals
and induced changes in the mitochondrial function of the
cells as evidenced by the increased ROS production in the
nZnO – FBS/PBS-treated cells. Given these findings, it is
readily apparent that the addition of serum proteins adds
a level of complexity to our experimental understanding
of NP-cell interactions. Further studies are needed to
examine how FBS coatings change NP-cellular surface in-
teractions, influence cellular uptake mechanisms, and
modify molecular interactions with other extracellular
matrix components. Additionally, these studies should be
extended to include newer 3D cellular culture models
which often employ complex biomolecular solution sys-
tems or molecular scaffolds to better mimic in vivo-like
environments for mechanistic biological assays [71, 72].
These complex culture systems will influence the forma-
tion of the NP biomolecular corona and change the diffu-
sion and sedimentation rates for NP dispersions especially
those containing additional serum proteins. Furthermore,
3D culture systems alter cellular growth patterns, metab-
olism, genetic expression, and phenotype organization
changing NP-induced cellular responses which could be
further influenced by the addition of NP coating materials
[72, 73]. Finally, these studies should be extended into
other cell types. Molecular coatings are often considered
as a means to achieve safer nZnO structures, yet little is
known about how these molecular coatings will influence
NP-cellular interactions with endothelial cells [18, 27, 74]
and other primary immune system cells [10].
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